27 March 2024 false No description of principal activity Taxfiler 2024.6 15598316 business:PrivateLimitedCompanyLtd 2024-03-27 2025-03-31 15598316 2024-03-26 15598316 2024-03-27 2025-03-31 15598316 business:AuditExempt-NoAccountantsReport 2024-03-27 2025-03-31 15598316 business:FilletedAccounts 2024-03-27 2025-03-31 15598316 2025-03-31 15598316 business:Director1 2024-03-27 2025-03-31 15598316 business:RegisteredOffice 2024-03-27 2025-03-31 15598316 core:WithinOneYear 2025-03-31 15598316 countries:EnglandWales 2024-03-27 2025-03-31 15598316 business:Micro-entities 2024-03-27 2025-03-31 iso4217:GBP xbrli:pure
Company Registration No. 15598316 (England and Wales)
Saffron Pharma Limited Unaudited accounts for the period from 27 March 2024 to 31 March 2025
Saffron Pharma Limited Annual report and unaudited accounts for the period from 27 March 2024 to 31 March 2025
CONTENTS
PAGE
Company information
3
Statement of financial position
4
- 2 -
Saffron Pharma Limited Company Information for the period from 27 March 2024 to 31 March 2025
Director
Declan Lismore
Company Number
15598316 (England and Wales)
Registered Office
32 Osbourne Avenue Kings Langley Hertfordshire WD4 8DB England
- 3 -
Saffron Pharma Limited Statement of Financial Position as at 31 March 2025
2025
£
Fixed assets
1,897
Current assets
4,680
Creditors: amounts falling due within one year
(5,538)
Net current liabilities
(858)
Total assets less current liabilities
1,039
Net assets
1,039
Capital and reserves
1,039
NOTES TO THE ACCOUNTS
1 Statutory information
Saffron Pharma Limited is a private company, limited by shares, registered in England and Wales, registration number 15598316. The registered office is 32 Osbourne Avenue, Kings Langley, Hertfordshire, WD4 8DB, England.
2 Average number of employees
During the period the average number of employees was 1.
For the period ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and FRS 105, The Financial Reporting Standard applicable to the Micro-entities Regime. The accounts have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. The profit and loss account has not been delivered to the Registrar of Companies.
Approved by the board on 25 March 2026
Declan Lismore Director Company Registration No. 15598316
- 4 -